PUBLISHER: IMARC | PRODUCT CODE: 1561658
PUBLISHER: IMARC | PRODUCT CODE: 1561658
Hemophilia Market Report by Type (Hemophilia A, Hemophilia B, Hemophilia C, and Others), Treatment (On-Demand, Prophylaxis), Therapy (Replacement Therapy, ITI Therapy, Gene Therapy), and Region 2024-2032
The global hemophilia market size reached US$ 13.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 31.2 Billion by 2032, exhibiting a growth rate (CAGR) of 9.9% during 2024-2032.
Hemophilia is an inherited medical disorder that affects the blood clotting process, wherein the blood clots abnormally. It results in spontaneous and excessive bleeding, easy bruising, and oozing after an injury, surgery, and dental procedures. It is caused by a hereditary lack of a coagulation factor that slows down blood clotting due to the deficiency of adequate blood-clotting proteins. It can be treated using medications, replacement therapy and injections of a clotting factor or plasma. Its treatment focuses on replacing missing proteins and preventing complications.
Hemophilia Market Trends:
The increasing number of hemophilic patients and rising occurrences of genetic abnormalities among individuals across the globe represents one of the key factors positively influencing the market. In addition, the rising diagnosis rate of the illness and the growing popularity of prophylactic treatment to cure hemophilia are offering lucrative growth opportunities to leading market players. Apart from this, governing agencies of various countries are organizing numerous campaigns to spread awareness about the benefits of early diagnosis and following appropriate procedures to facilitate the early screening of neonates, which is creating a positive outlook for the market. Additionally, they are increasingly funding research and development (R&D) activities due to the limited availability of treatment options. Furthermore, leading industry players are focusing on introducing technologically advanced diagnostic tools and therapies to enhance the efficacy and accuracy of hemophilia treatment, which is offering a favorable market outlook. Moreover, extensive investments in expanding the establishment of specialized hemophilia treatment centers (HTCs) across the globe are anticipated to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hemophilia market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, treatment, and therapy.
Breakup by Type:
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
Hemophilia A represents the largest market segment due to the rising prevalence of hemophilia A among individuals across the globe and the increasing requirement for patient care.
Breakup by Treatment:
- On-Demand
- Prophylaxis
On-demand treatment currently holds the largest market share as it is highly beneficial for patients with mild or moderate hemophilia who bleed less often.
Breakup by Therapy:
- Replacement Therapy
- ITI Therapy
- Gene Therapy
Replacement therapy is a standard therapy used to treat hemophilia as it helps replace the missing clotting factor among patients. It involves offering the missing clotting factor to patients from an external source.
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
North America exhibits a clear dominance in the market due to the increasing government spending on healthcare and research and development (R&D) activities, along with the presence of various leading players in the country.
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Bayer AG, BioMarin Pharmaceutical Inc., CSL Behring (CSL Limited), F. Hoffmann-La Roche AG, Grifols S.A., Kedrion S.p.A., Novo Nordisk A/S, Octapharma AG, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceutical Company Limited.
Key Questions Answered in This Report
- 1. What was the size of the global hemophilia market in 2023?
- 2. What is the expected growth rate of the global hemophilia market during 2024-2032?
- 3. What are the key factors driving the global hemophilia market?
- 4. What has been the impact of COVID-19 on the global hemophilia market?
- 5. What is the breakup of the global hemophilia market based on the type?
- 6. What is the breakup of the global hemophilia market based on the treatment?
- 7. What is the breakup of the global hemophilia market based on the therapy?
- 8. What are the key regions in the global hemophilia market?
- 9. Who are the key players/companies in the global hemophilia market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Hemophilia Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Hemophilia A
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Hemophilia B
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Hemophilia C
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Treatment
- 7.1 On-Demand
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Prophylaxis
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Therapy
- 8.1 Replacement Therapy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 ITI Therapy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Gene Therapy
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Baxter International Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Bayer AG
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 BioMarin Pharmaceutical Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 CSL Behring (CSL Limited)
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 F. Hoffmann-La Roche AG
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 Grifols S.A.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Kedrion S.p.A.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Novo Nordisk A/S
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Octapharma AG
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 SWOT Analysis
- 14.3.10 Pfizer Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Sanofi S.A.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Takeda Pharmaceutical Company Limited
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.1 Baxter International Inc.
List of Figures
- Figure 1: Global: Hemophilia Market: Major Drivers and Challenges
- Figure 2: Global: Hemophilia Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Hemophilia Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Hemophilia Market: Breakup by Type (in %), 2023
- Figure 5: Global: Hemophilia Market: Breakup by Treatment (in %), 2023
- Figure 6: Global: Hemophilia Market: Breakup by Therapy (in %), 2023
- Figure 7: Global: Hemophilia Market: Breakup by Region (in %), 2023
- Figure 8: Global: Hemophilia (Hemophilia A) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Hemophilia (Hemophilia A) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Hemophilia (Hemophilia B) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Hemophilia (Hemophilia B) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Hemophilia (Hemophilia C) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Hemophilia (Hemophilia C) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Hemophilia (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Hemophilia (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Hemophilia (On-Demand) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Hemophilia (On-Demand) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Hemophilia (Prophylaxis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Hemophilia (Prophylaxis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Hemophilia (Replacement Therapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Hemophilia (Replacement Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Hemophilia (ITI Therapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Hemophilia (ITI Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Hemophilia (Gene Therapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Hemophilia (Gene Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: North America: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: North America: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: United States: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: United States: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Canada: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Canada: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Asia-Pacific: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Asia-Pacific: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: China: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: China: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Japan: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Japan: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: India: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: India: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: South Korea: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: South Korea: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Australia: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Australia: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Indonesia: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Indonesia: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Others: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Others: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Europe: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Europe: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Germany: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Germany: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: France: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: France: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: United Kingdom: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: United Kingdom: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Italy: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Italy: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Spain: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Spain: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Russia: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Russia: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Others: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Others: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Latin America: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Latin America: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Brazil: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Brazil: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Mexico: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Mexico: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Others: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Others: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Middle East and Africa: Hemophilia Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Middle East and Africa: Hemophilia Market: Breakup by Country (in %), 2023
- Figure 74: Middle East and Africa: Hemophilia Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Global: Hemophilia Industry: SWOT Analysis
- Figure 76: Global: Hemophilia Industry: Value Chain Analysis
- Figure 77: Global: Hemophilia Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Hemophilia Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Hemophilia Market Forecast: Breakup by Type (in Million US$), 2024-2032
- Table 3: Global: Hemophilia Market Forecast: Breakup by Treatment (in Million US$), 2024-2032
- Table 4: Global: Hemophilia Market Forecast: Breakup by Therapy (in Million US$), 2024-2032
- Table 5: Global: Hemophilia Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Hemophilia Market: Competitive Structure
- Table 7: Global: Hemophilia Market: Key Players
